Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
Add more filters










Publication year range
1.
J Neurosci ; 23(14): 6013-22, 2003 Jul 09.
Article in English | MEDLINE | ID: mdl-12853419

ABSTRACT

The transcription of neurotrophic factors, i.e., basic fibroblast growth factor (bFGF) and brain-derived neurotrophic factor (BDNF) is regulated by glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) activation despite the lack of a classical glucocorticoid response element in their promoter region. A time course for corticosterone (10 mg/kg, s.c.) in adrenalectomized rats revealed a peak hormone effect at the 4 hr time interval for bFGF (110-204% increase), BDNF (53-67% decrease), GR (53-64% decrease), and MR (34-56% decrease) mRNA levels in all hippocampal subregions using in situ hybridization. c-fos mRNA levels were affected exclusively in the dentate gyrus after 50 min to 2 hr (38-46% decrease). Furthermore, it was evaluated whether corticosterone regulation of these genes depends on interactions with the transcription factor complex activator protein-1. c-fos antisense oligodeoxynucleotides were injected into the dorsal hippocampus of adrenalectomized rats. Corticosterone was given 2 hr later, and the effects on gene expression were measured 4 hr later. In CA1, antisense treatment significantly and selectively enhanced the hormone action on the expression of bFGF (44% enhanced increase) and BDNF (38% enhanced decrease) versus control oligodeoxynucleotide treatment. In addition, an upregulation of c-fos expression (89% increase) was found. There were no effects of c-fos antisense on hippocampal GR and MR expression. Thus it seems that a tonic c-fos mechanism exists within CA1, which reduces GR- and MR-mediated effects on expression of bFGF and BDNF.


Subject(s)
Corticosterone/metabolism , Hippocampus/metabolism , Nerve Growth Factors/metabolism , Proto-Oncogene Proteins c-fos/metabolism , Adrenalectomy , Animals , Biomarkers/analysis , Corticosterone/blood , Corticosterone/pharmacology , Gene Expression Regulation/drug effects , Hippocampus/drug effects , In Situ Hybridization , Male , Nerve Growth Factors/genetics , Oligonucleotides, Antisense/pharmacokinetics , Oligonucleotides, Antisense/pharmacology , Proto-Oncogene Proteins c-fos/antagonists & inhibitors , Proto-Oncogene Proteins c-fos/genetics , RNA, Messenger/metabolism , Radioimmunoassay , Rats , Rats, Sprague-Dawley , Receptors, Glucocorticoid/metabolism , Stress, Physiological/metabolism , Tissue Distribution
2.
Neuroreport ; 12(12): 2615-7, 2001 Aug 28.
Article in English | MEDLINE | ID: mdl-11522935

ABSTRACT

The effects of i.c.v. injection of AIDA, a group I mGluR antagonist, were studied on the nigral DA cells after MPTP-induced injury in the black mouse, using TH immunocytochemistry and unbiased stereology. MPTP reduced the total number of TH-IR neurons by 55.2% and non-TH-IR neurons by 27.5%. A 15 min AIDA pre-treatment (10 nmol) selectively counteracted the loss of TH-IR cells caused by MPTP as evaluated 10 days after the insult without changing the total number of non-neuronal cell nuclei. The results suggest that group I mGluR antagonists may have a neuroprotective role against MPTP-induced degeneration of DA neurons and thus probably also against neurodegenerative processes occurring in Parkinson's disease.


Subject(s)
Dopamine/metabolism , Excitatory Amino Acid Antagonists/administration & dosage , Indans/administration & dosage , MPTP Poisoning/prevention & control , Neurons/drug effects , Receptors, Metabotropic Glutamate/antagonists & inhibitors , Substantia Nigra/drug effects , 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/administration & dosage , Animals , Cell Count , Cell Size/drug effects , Coloring Agents , Immunohistochemistry , Injections, Intraventricular , MPTP Poisoning/pathology , Male , Mice , Mice, Inbred C57BL , Neurons/pathology , Neuroprotective Agents/administration & dosage , Substantia Nigra/pathology , Tyrosine 3-Monooxygenase/analysis , Tyrosine 3-Monooxygenase/biosynthesis
3.
Neuroreport ; 12(1): 141-5, 2001 Jan 22.
Article in English | MEDLINE | ID: mdl-11201075

ABSTRACT

A transcriptional regulation of bFGF expression via both gluco- and mineralocorticoid receptors is known to exist. In the present study the glial nuclear fraction of bFGF transcripts was studied in sham-operated (SHAM), adrenalectomized (ADX), and corticosterone-treated ADX rats in subregions of the dorsal hippocampal formation. A substantial increase was observed in the population of bFGF RNA-expressing glial cells after acute corticosterone treatment (10 mg/kg, s.c.) in subregions of the CA1 area and the dentate gyrus but no changes were observed after adrenalectomy. The levels of glial nuclear bFGF transcripts were similar in all the experimental groups. These data suggest that in a subpopulation of hippocampal glial cells corticosterone regulates bFGF gene expression transcriptionally in an on/off manner.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Brain-Derived Neurotrophic Factor , Corticosterone/pharmacology , Gene Expression/drug effects , Nerve Tissue Proteins/drug effects , Neuroglia/drug effects , Adrenalectomy , Animals , Gene Expression/physiology , Hippocampus/drug effects , Hippocampus/metabolism , Male , Nerve Tissue Proteins/metabolism , Neuroglia/metabolism , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley
4.
Neuroreport ; 11(12): 2691-4, 2000 Aug 21.
Article in English | MEDLINE | ID: mdl-10976945

ABSTRACT

The role of G-proteins in D2 receptor supersensitivity was studied in striatal membranes from rats with unilateral 6-hydroxydopamine (6-OHDA) induced lesions of the nigral dopamine (DA) system. Thirteen months after the lesion the number of [3H]raclopride binding sites was increased in the DA denervated striatum, but no changes in ligand binding affinities and in proportion of high-affinity agonist binding sites could be detected. The affinity of [35S]GTPgammaS binding was unaltered after the striatal DA denervation, whereas the binding affinity of GDP was decreased in the DA denervated as compared to the intact striatum. It is proposed that the decrease in GDP binding affinity to D2 DA receptor-coupled G proteins is an important factor in the D2 receptor supersensitivity following degeneration of the striatal DA terminals.


Subject(s)
Corpus Striatum/physiology , Dopamine/physiology , Guanosine Diphosphate/metabolism , Animals , Binding Sites , Binding, Competitive , Denervation , Dopamine Antagonists/metabolism , Guanosine 5'-O-(3-Thiotriphosphate)/metabolism , Ligands , Male , Membranes/metabolism , Raclopride/metabolism , Rats , Rats, Sprague-Dawley , Reference Values
5.
Eur J Neurosci ; 12(7): 2505-14, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10947826

ABSTRACT

This report characterizes an in vivo intracerebral long-distance diffusion model using dual-probe microdialysis. Two probes 1 mm apart were implanted into the striatum of control and 6-hydroxydopamine (6-OHDA)-lesioned halothane-anaesthetized male rats. Either tritiated dopamine (500 nM 3H-DA) or mannitol (1.5 microM 3H-mannitol) was infused continuously for 5 h, while samples were collected from the other probe. Samples (10 microl) were counted by liquid scintillation. For the DA-infused rats, another 10 microL was separated with high-pressure liquid chromatography (HPLC)-electrochemical detection into individual fractions containing 3,4-dihydroxy phenylacetic acid (DOPAC) and homovanillinic acid (HVA), and counted for beta-decay. The total transfer of 3H-labelled compounds described the overall effect of cellular uptake, metabolism and clearance into the microcirculation, and was compared with that of an extracellular marker, 3H-mannitol. The migration reached steady-state levels, generating an equilibrium between delivery and removal from the extracellular space. The half-time of the steady-state values, t50%, was in all cases lower in 6-OHDA-treated rats compared with control. In addition, the t50% values of 3H-mannitol were lower than those following the 3H-dopamine infusion in both control or 6-OHDA-lesioned rats. However, it was not possible to detect any unmetabolized 3H-dopamine at the 1 mm distance. In conclusion, the dual-probe microdialysis approach proved to be a valid method to study in vivo diffusion and migration in the brain, and the intracerebral spread of compounds highly depends on the nature of the compound infused.


Subject(s)
Corpus Striatum/metabolism , Diuretics, Osmotic/pharmacokinetics , Dopamine/pharmacokinetics , Mannitol/pharmacokinetics , Anesthetics, Inhalation , Animals , Denervation , Diffusion , Extracellular Space/metabolism , Halothane , Male , Microdialysis , Oxidopamine , Rats , Rats, Sprague-Dawley , Sympatholytics , Tritium
6.
Exp Neurol ; 164(1): 154-65, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10877926

ABSTRACT

Grafting of ventral mesencephalic tissue in Parkinson's disease results in a partial dopaminergic reinnervation of host brain and dopamine agonist-induced rotational behavior is not completely reversed. To study a possible malfunction of the grafts, extracellular recordings with local applications of quinpirole were utilized and the neurophysiological results showed that a normalization of the upregulated dopamine D2 receptor supersensitivity occurred in reinnervated areas of the host striatum as well as in noninnervated areas remote from the graft innervation. Furthermore, the inhibitory effects on striatal nerve cell firing rate by the D1 receptor agonist SKF 81297 were not different in noninnervated or reinnervated areas of the striatum compared to the control side as seen from the dose-response curves. However, spontaneous striatal neuronal firing was significantly upregulated in noninnervated areas, while it was normalized in areas reached by graft-derived nerve fibers. Dual-probe microdialysis studying potassium-evoked glutamate release revealed that there was no difference in extracellular glutamate levels measured within or lateral to graft dopamine reinnervation. Thus, the upregulated spontaneous activity was not due to a difference in extracellular glutamate levels. The remaining rotational behavior seen after grafting was studied and recordings were performed in the striatum following systemic injection of the D1/D2 agonist apomorphine. The results revealed that apomorphine at the dose used to elicit turning behavior (0.05 mg/kg) still affected striatal neurons in noninnervated areas, while no effect was detected in reinnervated areas and in the intact side. However, a lower dose of apomorphine (0.005 mg/kg) showed no effects on striatal firing in graft reinnervated striata but only after dopamine depletion. In conclusion, the D2 supersensitivity is downregulated in graft-reinnervated striatum as well as in striatal areas lateral to the reinnervation when using selective D2 agonists, but the downregulation is not completely normalized when studying combined effects of D1/D2 agonists. Furthermore, the striatal neurons were firing significantly faster in noninnervated areas compared to reinnervated areas of graft-reinnervated striatum, which was most likely not due to changes in the glutamatergic input.


Subject(s)
Corpus Striatum/metabolism , Mesencephalon/transplantation , Parkinson Disease, Secondary/metabolism , Parkinson Disease, Secondary/surgery , Receptors, Dopamine D2/metabolism , Animals , Apomorphine/pharmacology , Benzazepines/pharmacology , Brain Tissue Transplantation , Corpus Striatum/drug effects , Corpus Striatum/surgery , Dopamine/metabolism , Dopamine Agonists/pharmacology , Dose-Response Relationship, Drug , Female , Fetal Tissue Transplantation , Glutamic Acid/metabolism , Membrane Potentials/drug effects , Mesencephalon/embryology , Microdialysis , Microelectrodes , Motor Activity/drug effects , Oxidopamine , Parkinson Disease, Secondary/chemically induced , Quinpirole/pharmacology , Rats , Rats, Sprague-Dawley , Tyrosine 3-Monooxygenase/metabolism
7.
Neuroreport ; 11(7): 1427-31, 2000 May 15.
Article in English | MEDLINE | ID: mdl-10841351

ABSTRACT

Claudins are components of the tight junctional complex in epithelial and endothelial cells. We characterized the composition of tight junctions in the choroid plexus of the lateral ventricle in the rat brain and tested whether protein kinase C induced changes in their composition. Claudin-1, -2 and -5 were present in the epithelial cells at and near the tight junctions, respectively. In the endothelial cells, claudin-5 was stronger expressed than claudin-1 and -2. Twenty-four hours after the phorbolester injection into the ventricle, claudin-1 immunoreactivity of the epithelial cells was increased and spread to the cytoplasm. The claudin-2 and -5 immunoreactivities were reduced. These findings are consistent with an influence of protein kinase C on the composition of the tight junctions in the choroid plexus.


Subject(s)
Choroid Plexus/cytology , Epithelial Cells/cytology , Membrane Proteins/biosynthesis , Protein Kinase C/metabolism , Tight Junctions/enzymology , Animals , Antibodies , Blood-Brain Barrier/physiology , Carcinogens/pharmacology , Choroid Plexus/blood supply , Claudin-1 , Claudins , Epithelial Cells/drug effects , Epithelial Cells/enzymology , Male , Membrane Proteins/analysis , Membrane Proteins/immunology , Rats , Rats, Sprague-Dawley , Specific Pathogen-Free Organisms , Tetradecanoylphorbol Acetate/pharmacology , Tight Junctions/chemistry
8.
Brain Res ; 854(1-2): 197-206, 2000 Jan 31.
Article in English | MEDLINE | ID: mdl-10784122

ABSTRACT

The molecular composition and functional properties of cell-cell junctions of choroid plexus epithelial cells and the ependyma of the lateral ventricular wall were investigated in the rat brain. Expression studies of cadherin and alpha- and beta-catenins, as well as expression of occludin and ZO-1, indicated that cell adherens and tight junctions were present in both choroid plexus epithelial cells and in ependymal cells. We then tested the hypothesis that phorbolester in vivo can induce changes in the expression level of adherens and tight junction molecules at the blood-cerebrospinal fluid (CSF) barrier as well as in the ependyma. In addition, the functional properties of the ependymal junctions were tested by injection of dextran 3000 into the striatum after phorbolester application. Twenty-four hours after phorbolester-injection into the lateral ventricle of the rat brain, the expression patterns of tight and adherens junction molecules were markedly changed in the epithelial cells of the choroid plexus. The adherens junction proteins cadherin and beta-catenin were reduced in both the ependymal cells of the lateral ventricle and choroid plexus epithelial cells. In addition, the occludin-immunoreactivity of the choroid plexus epithelial cells was strongly reduced. However, the ZO-1 immunoreactivity was not affected by the phorbol ester-treatment and the alpha-catenin immunoreactivity was not changed. Furthermore, phorbol ester injection induced a reduction of the volume of intrastriatal injected biotinylated dextran (m.w. 3000), which is consistent with a modulatory influence of protein kinase C activation on the clearance capacity of the brain.


Subject(s)
Choroid Plexus/drug effects , Ependyma/drug effects , Intercellular Junctions/drug effects , Tetradecanoylphorbol Acetate/pharmacology , Tight Junctions/drug effects , Animals , Corpus Striatum , Dextrans/pharmacokinetics , Epithelium/drug effects , Injections , Male , Membrane Proteins/metabolism , Occludin , Phosphoproteins/metabolism , Rats , Rats, Sprague-Dawley , Zonula Occludens-1 Protein
9.
Exp Neurol ; 161(1): 153-66, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10683281

ABSTRACT

In spite of numerous studies utilizing intraventricular administration of porcine galanin (1-29), little is known about the spread and cellular distribution of exogenous galanin following intraventricular administration. In this study a discrete nerve cell body population with their dendrites became strongly galanin immunoreactive (IR) in the dorsal hippocampus following intraventricular porcine galanin (1.5 nmol/rat). Time course experiments showed that after time intervals of 10 and 20 min, but not at 60 min, scattered small- to medium-sized galanin-IR nerve cell bodies and their dendrites were present in all layers of the dorsal and ventral hippocampus. In double-immunolabeling experiments most of these nerve cells were identified as putative GABA interneurons costoring NPY-IR or somatostatin-IR in some cases. Twenty minutes after intraventricular injection of artificial cerebrospinal fluid (aCSF), only endogenous punctate and coarse galanin-IR terminals were found, but no galanin-IR cell bodies. Intrahippocampal injection of fluorophore-labeled galanin resulted in the appearance of fluorescent nerve cell bodies with the same morphology and localization as in the above experiments. Coadministration of the putative galanin antagonist M35 (0.5 nmol) and galanin (1.5 nmol) resulted in a reduced number of galanin-IR nerve cell bodies in the hippocampus of half of the rats. These findings support the existence of a population of putative hippocampal GABA interneurons with the ability to internalize and concentrate galanin and/or its fragments present in the extracellular fluid, possibly mediated by galanin receptors.


Subject(s)
Dentate Gyrus/cytology , Galanin/pharmacokinetics , Interneurons/enzymology , Animals , Biological Transport/physiology , Bradykinin/analogs & derivatives , Bradykinin/pharmacology , Fluorescent Antibody Technique , Galanin/pharmacology , Glutamate Decarboxylase/analysis , Glutamate Decarboxylase/immunology , Injections, Intraventricular , Interneurons/chemistry , Male , Neuropeptide Y/analysis , Neuropeptide Y/immunology , Peptide Fragments/pharmacology , Rats , Rats, Sprague-Dawley , Receptor, Serotonin, 5-HT2A , Receptors, Serotonin/analysis , Receptors, Serotonin/immunology , Somatostatin/analysis , Somatostatin/immunology , Swine
10.
Neurosci Lett ; 274(1): 5-8, 1999 Oct 15.
Article in English | MEDLINE | ID: mdl-10530506

ABSTRACT

The effect of a subchronic (4-week) exposure to low concentrations of toluene (40 or 80 parts per million, ppm) on the brain dopaminergic system has been examined in a rat model of Parkinson's disease. A unilateral lesion of the substantia nigra (SN) dopamine (DA) nerve cells was performed by injection of a low dose of 6-hydroxydopamine (6-OH DA). The peak activity of contralateral rotational behavior induced by apomorphine was significantly decreased after exposure to 80 ppm toluene. Analysis of the neostriatum and SN ipsilateral to the lesion revealed that toluene (80 ppm, but not 40 ppm) counteracted the 6-OH DA-induced reductions of DA tissue levels both within the SN and the neostriatum. Also the lesion-induced reduction of immunoreactivity for tyrosine hydroxylase (TH IR) in the neostriatum was partly counteracted by the toluene exposure (80 ppm). In conclusion, a subchronic exposure to low doses of toluene (80 ppm) leads to signs of reduced dysfunction of the nigrostriatal dopaminergic system after the neurotoxic treatment.


Subject(s)
Dopamine/metabolism , Neostriatum/drug effects , Oxidopamine/toxicity , Parkinsonian Disorders/metabolism , Substantia Nigra/drug effects , Toluene/administration & dosage , 3,4-Dihydroxyphenylacetic Acid/metabolism , Animals , Apomorphine/pharmacology , Behavior, Animal/drug effects , Denervation , Injections, Intraventricular , Male , Motor Activity/drug effects , Neostriatum/metabolism , Parkinsonian Disorders/chemically induced , Parkinsonian Disorders/physiopathology , Rats , Rats, Sprague-Dawley , Substantia Nigra/metabolism , Toluene/pharmacology , Tyrosine 3-Monooxygenase/metabolism
11.
Neuroscience ; 91(1): 69-80, 1999.
Article in English | MEDLINE | ID: mdl-10336061

ABSTRACT

Volume transmission in the brain is mediated by the diffusion of neurotransmitters, modulators and other neuroactive substances in the extracellular space. The effects of nitric oxide synthase inhibition on extracellular space diffusion properties were studied using two different approaches, the histological dextran method and the real-time iontophoretic tetramethylammonium method. The spread of biotinylated dextran (mol. wt 3000) in the extracellular space was measured morphometrically following microinjection into the neostriatum of male rats. Two parameters were used to describe the spread of biotinylated dextran in brain tissue, namely, total volume of spread and the mean grey value. The nonspecific nitric oxide synthase inhibitors NG-nitro-L-arginine methyl ester (10-100 mg/kg) and NG-monomethyl-L-arginine acetate (30-200 mg/kg) decreased the total volume of spread of dextran in a dose-dependent manner. 7-Nitroindazole monosodium salt (50-100 mg/kg), a specific neuronal nitric oxide synthase inhibitor, did not change the total volume of spread of dextran. Using the tetramethylammonium method, the extracellular space diffusion properties can be described by the volume fraction (alpha = extracellular space volume/total tissue volume), tortuosity lambda (lambda2 = free diffusion coefficient/apparent diffusion coefficient in tissue), and non-specific uptake kappa' [Nicholson C. and Syková E. (1998) Trends Neurosci. 21, 207-215]. Nitric oxide synthase inhibition by NG-nitro-L-arginine methyl ester (50 mg/kg) had relatively little effect on volume fraction and tortuosity, and no changes were observed after NG-monomethyl-L-arginine acetate (20 mg/kg) or 7-nitroindazole monosodium salt (100 mg/kg) treatment. A substantial increase was found only in non-specific uptake, by 13% after NG-nitro-L-arginine methyl ester and by 16% after NG-monomethyl-L-arginine acetate, which correlates with the decreased total volume of spread of dextran observed with the dextran method. NG-Nitro-L-arginine methyl ester treatment (100 mg/kg) decreased striatal blood flow and increased mean arterial blood pressure. The changes in dextran spread and non-specific uptake can be explained by an increased capillary clearance following the inhibition of endothelial nitric oxide synthase, as neuronal nitric oxide synthase inhibition had no effect. The observed changes after non-specific nitric oxide synthase inhibition may affect the extracellular space concentration of neurotransmitters and modulators, and influence volume transmission pathways in the central nervous system by increased capillary and/or cellular clearance rather than by changes in extracellular space diffusion.


Subject(s)
Biotin/analogs & derivatives , Dextrans/pharmacokinetics , Enzyme Inhibitors/pharmacology , Extracellular Space/metabolism , Neostriatum/drug effects , Nitric Oxide Synthase/antagonists & inhibitors , Animals , Biotin/administration & dosage , Biotin/pharmacokinetics , Blood-Brain Barrier/drug effects , Cerebrovascular Circulation/drug effects , Dextrans/administration & dosage , Diffusion , Dose-Response Relationship, Drug , Extracellular Space/drug effects , Extracellular Space/enzymology , Fluorescent Dyes , Ganglionic Stimulants , Image Processing, Computer-Assisted , Indazoles/pharmacology , Male , NG-Nitroarginine Methyl Ester/pharmacology , Neostriatum/enzymology , Neostriatum/ultrastructure , Nerve Tissue Proteins/metabolism , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type I , Quaternary Ammonium Compounds , Rats , Rats, Sprague-Dawley , Time Factors
12.
Neuroscience ; 83(3): 723-40, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9483557

ABSTRACT

Several findings show a neuroprotective effect of nicotine treatment in different experimental models, and a negative correlation has been observed between cigarette smoking and the incidence of Parkinson's disease. It seems possible that nicotine may in part exert its neuroprotective actions by favouring the synthesis of neurotrophic factors. The aim of this study was to determine whether the nicotine treatment could be associated with the induction of a neurotrophic factor in brain regions with nicotinic receptors. Thus, we analysed by in situ hybridization and RNAse protection assay the effects of (-)nicotine on basic fibroblast growth factor messenger RNA and by immunocytochemistry fibroblast growth factor-2 protein in the tel- and diencephalon of rats following single or acute intermittent (-)nicotine treatment. The present results showed that acute intermittent (-)nicotine treatment (four i.p. injections at intervals of 30 min), but not single injections, lead to a substantial and dose-related (0.1-2 mg/kg) up-regulation of fibroblast growth factor-2 messenger RNA levels in the cerebral cortex, in the hippocampus, in the striatum and ventral midbrain. This induction of fibroblast growth factor-2 expression peaked 4 h after the first injection and returned to normal levels within 24 h. The change of fibroblast growth factor-2 messenger RNA levels was associated with increased fibroblast growth factor-2 immunoreactivity mainly localized to nerve cells. The treatment was effective also when repeated in the same animals three or five days after the first injection. The pre-treatment with the non-competitive (-)nicotine receptor antagonist mecamylamine blocked the (-)nicotine effects on fibroblast growth factor-2 messenger RNA levels. In the above areas, no changes were observed in the fibroblast growth factor-1, 2 and 3 receptor messenger RNA levels nor in brain-derived neurotrophic factor messenger RNA levels. The present data indicate an ability of intermittent (-)nicotine to increase fibroblast growth factor-2 in many tel- and diencephalic areas. In view of the trophic function of fibroblast growth factor-2, the previously observed neuroprotective effects of (-)nicotine may at least in part involve an activation of the neuronal fibroblast growth factor-2 signalling, and open up new avenues for treatment of Parkinson's disease and Alzheimer's disease based on the existence of nicotinic receptor subtypes enhancing fibroblast growth factor-2 signalling in many regions of the tel- and diencephalon.


Subject(s)
Diencephalon/metabolism , Fibroblast Growth Factor 2/genetics , Fibroblast Growth Factor 2/metabolism , Neuroprotective Agents/pharmacology , Nicotine/pharmacology , RNA, Messenger/metabolism , Telencephalon/metabolism , Animals , Brain-Derived Neurotrophic Factor/genetics , Immunohistochemistry , Rats , Rats, Sprague-Dawley , Time Factors
13.
Neuroreport ; 8(11): 2623-9, 1997 Jul 28.
Article in English | MEDLINE | ID: mdl-9261839

ABSTRACT

Endothelin-1 (ET-1) was unilaterally applied onto the surface of the dorsal frontoparietal cortex of the rat. Cortical blood flow measurements using laser-Doppler flowmetry demonstrated dose-dependent reductions of frontoparietal cortical blood flow. Histological analysis demonstrated dose-related lesions and the time course was followed using MRI. The lesions appear to be associated with a large penumbra area indicated by morphological characteristics. Thus, cortical surface exposure to ET-1 may produce graded lesions of the frontoparietal cortex related to local ischemia.


Subject(s)
Endothelin-1/toxicity , Frontal Lobe/drug effects , Ischemic Attack, Transient/physiopathology , Parietal Lobe/drug effects , Animals , Blood Pressure/drug effects , Cerebral Cortex/blood supply , Cerebral Cortex/diagnostic imaging , Cerebral Cortex/pathology , Cerebrovascular Circulation/drug effects , Disease Models, Animal , Frontal Lobe/pathology , Frontal Lobe/physiopathology , Ischemic Attack, Transient/pathology , Magnetic Resonance Imaging , Male , Parietal Lobe/pathology , Parietal Lobe/physiopathology , Rats , Rats, Sprague-Dawley , Regional Blood Flow/drug effects , Ultrasonography
14.
Neurosci Lett ; 217(1): 61-5, 1996 Oct 11.
Article in English | MEDLINE | ID: mdl-8905740

ABSTRACT

The potential neurotoxicity of the solvent toluene to the nigrostriatal dopaminergic system was assessed in a rat model of Parkinson's disease. Rats, 1 day after a unilateral injection of 6-hydroxydopamine (6-OH DA) into the substantia nigra, inhaled air or different concentrations of toluene (80, 300 or 1000 ppm), 6 h/day for 3 days. The animals were sacrificed 2 days after the last exposure and biochemical measurements of catecholamines and 3,4-dihydroxyphenylacetic acid (DOPAC) were performed in the neostriatum and substantia nigra. Toluene at 80 and 1000 ppm significantly enhanced the depletion of striatal DOPAC levels induced by the lesion and produced at 80 and 300 ppm a trend for intensifying the 6-OH DA-induced depletion of striatal DA stores. The alterations induced after the combined challenge to the dopaminergic nigrostriatal system may reflect endangering actions of toluene.


Subject(s)
Corpus Striatum/drug effects , Dopamine/physiology , Neurotoxins/toxicity , Oxidopamine/toxicity , Parkinson Disease, Secondary/chemically induced , Substantia Nigra/drug effects , Toluene/toxicity , 3,4-Dihydroxyphenylacetic Acid/metabolism , Animals , Corpus Striatum/metabolism , Dopamine/metabolism , Drug Administration Schedule , Drug Synergism , Male , Norepinephrine/metabolism , Rats , Rats, Sprague-Dawley , Substantia Nigra/metabolism
15.
Brain Res ; 730(1-2): 1-16, 1996 Aug 19.
Article in English | MEDLINE | ID: mdl-8883883

ABSTRACT

Basic fibroblast growth factor (bFGF) gene expression as well as its immunoreactivity were studied after partial unilateral hemitransection of the rat brain during a time course of 24 h, 72 h, 7 and 14 days. The mechanical injury resulted in a global increase of bFGF gene expression at the 24-h time interval. This global increase was seen at the ipsilateral site at the level of the lesion as well as rostral to the lesion in the ipsilateral hemisphere. The upregulation in bFGF gene expression was in most of the areas investigated due to an upregulation in glial cells as seen by means of nonradioactive in situ hybridization compared with immunocytochemistry for glial fibrillary acidic protein (GFAP). Basic FGF immunoreactivity (IR) was increased around the lesion in glial cell nuclei 7 days after the injury. This increase was also detected in GFAP positive glial cells surrounding small vessels in the lesioned area. Moreover, in the present paper we demonstrate increased tenascin immunoreactivity in the lesioned area 7 days after injury. The tenascin IR was increased at the edges of the lesion as well as in vessel like structures. The tenascin IR was partially codistributed with GFAP IR in the lesioned area. The lesion was also characterized by an increase in vimentin IR as well as in laminin IR. It is suggested that the observed changes in the expression of bFGF, matrix proteins (laminin, tenascin) and intermediate filaments (vimentin) are involved in (a) tissue repair, (b) protection of neuronal cells from excitotoxic influences and (c) formation of new vessels in the lesioned area.


Subject(s)
Brain/metabolism , Denervation , Fibroblast Growth Factor 2/metabolism , Tenascin/metabolism , Animals , Astrocytes/metabolism , Brain/cytology , Fibroblast Growth Factor 2/genetics , Immunohistochemistry , In Situ Hybridization , Male , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley
16.
J Neurosci ; 15(10): 6747-56, 1995 Oct.
Article in English | MEDLINE | ID: mdl-7472433

ABSTRACT

The immunoreactivity for thioredoxin, which catalyzes protein disulfide reductions, has previously been shown to exist in nerve cells and their axons. Here we demonstrate the localization of thioredoxin mRNA as revealed by in situ hybridization in the rat brain. The gene is expressed in nerve cells of a variety of brain regions, for example, the cerebral cortex, the piriform cortex, the medial preoptic area, the CA3/CA4 region of the hippocampal formation, the dentate gyrus, the paraventricular nucleus of the hypothalamus, the arcuate nucleus, the substantia nigra pars compacta, the locus coeruleus, the ependyma of the 4th ventricle, and the epithelial cells of the choroid plexus. This distribution implicates an important function in nerve cell metabolism, especially in regions with high energy demands and indicates a role of the choroid plexus in nerve cell protection from environmental influences. It was found that after mechanical injury induced by partial unilateral hemitransection the thioredoxin mRNA expression is upregulated in the lesioned area and spreads to the cortical hemispheres at the lesioned level. This induction suggests a function of thioredoxin in the regeneration machinery of the brain following mechanical injury and oxidative stress.


Subject(s)
Brain/metabolism , Thioredoxins/metabolism , Animals , Denervation , Diencephalon/physiology , In Situ Hybridization , Male , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Thioredoxins/genetics , Tissue Distribution
17.
Brain Res ; 662(1-2): 11-24, 1994 Oct 31.
Article in English | MEDLINE | ID: mdl-7859063

ABSTRACT

In the present study the hypothesis has been tested if the dopamine releasing drug D-amphetamine via volume transmission can, at least partly, restore dopamine communication in the dopaminergically denervated neostriatum of rats. The experimental model used, has been a unilateral 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons, based on nigral microinjections of this neurotoxin. Studies on c-fos like immunoreactivity after systemic D-amphetamine treatment demonstrated a wide-spread appearance of c-fos like immunoreactive neuronal nuclear profiles within the neostriatum on both the unlesioned and denervated side. In the unlesioned neostriatum a peak density of c-fos like immunoreactive profiles was found within the central part of the neostriatum, while on the denervated side the distribution pattern of c-fos like immunoreactive profiles peaked medially and gradually declined in a lateral direction. The microdialysis experiments demonstrated, after systemic d-amphetamine treatment, a marked and sustained increase of extracellular dopamine levels in the neostriatum on the unlesioned side, while no increases in the extracellular dopamine levels were observed on the dopaminergically denervated neostriatum. In the electrophysiological experiments, systemic D-amphetamine treatment produced an inhibition of the neuronal activity on the denervated side which showed a significant increase in basal discharge rate compared with the recordings obtained from the striata on the unlesioned side. The present immunocytochemical microdialysis and electrophysiological analysis provides evidence that in the unilaterally markedly dopamine depleted neostriatum with clearcut signs of dopamine receptor supersensitivity (rotational behaviour results), dopamine transmission may be partly restored via systemic D-amphetamine treatment through the release of dopamine, predominantly from the unlesioned neostriatum, which may diffuse into the cerebrospinal fluid to reach the contralateral dopaminergically denervated neostriatum.


Subject(s)
Dextroamphetamine/pharmacology , Dopamine/physiology , Neostriatum/physiology , Synaptic Transmission/physiology , Animals , Denervation , Dopamine/metabolism , Electrophysiology , Genes, fos , Immunohistochemistry , Male , Microdialysis , Neostriatum/cytology , Neostriatum/drug effects , Nerve Endings/drug effects , Nucleus Accumbens/drug effects , Nucleus Accumbens/metabolism , Oxidopamine , Rats , Rats, Sprague-Dawley , Stereotyped Behavior/drug effects , Synaptic Transmission/drug effects , Tyrosine 3-Monooxygenase/metabolism
18.
Clin Investig ; 72(4): 262-8, 1994 Mar.
Article in English | MEDLINE | ID: mdl-8043972

ABSTRACT

Previous studies have demonstrated that chronic continuous nicotine treatment via minipumps partially protects against mechanically induced degeneration of the nigrostriatal dopamine neurons in the male Sprague-Dawley rat. In the present study we investigated how a 4-week continuous infusion with (-)-nicotine via minipumps implanted subcutaneously in the male Sprague-Dawley rat (0.125 mg/kg-1 h-1) influences the anterograde and retrograde changes occurring in the septohippocampal cholinergic neurons following a unilateral transection of the fimbria fornix. Choline acetyltransferase and acetylcholinesterase immunocytochemistry was performed in combination with computer-assisted morphometry and microdensitometry. Measurements of choline acetyltransferase enzyme activity was performed in the dorsal hippocampus. The chronic nicotine infusion significantly increased the disappearance of the choline acetyltransferase immunoreactive nerve cell area within the medial septal nucleus of the lesioned side. However, the disappearance of the acetylcholinesterase immunoreactive nerve terminals within the dentate gyrus (molecular layer) and of choline acetyltransferase enzyme activity within the dorsal hippocampus was not found to be influenced by the chronic nicotine infusion. Thus, chronic infusion of (-)-nicotine does not appear to exert any protective activity on mechanically injured septohippocampal cholinergic neurons but may instead increase their dysfunction. In comparison with the dopaminergic neurons it may therefore be that the continuous chronic nicotine exposure does not lead to sufficient desensitization of the nicotinic cholinoceptors of the cholinergic neurons to reduce the chronic influx of sodium and calcium ions via the nicotinic ion channels and thus intraneuronal calcium levels and energy demands.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Choline O-Acetyltransferase/metabolism , Hippocampus/physiology , Nerve Degeneration/drug effects , Neurons/enzymology , Nicotine/pharmacology , Septal Nuclei/enzymology , Acetylcholinesterase/metabolism , Animals , Hippocampus/surgery , Immunohistochemistry , Male , Neurons/ultrastructure , Nicotine/administration & dosage , Rats , Rats, Sprague-Dawley , Septal Nuclei/cytology
19.
Brain Res ; 625(1): 45-56, 1993 Oct 15.
Article in English | MEDLINE | ID: mdl-8242399

ABSTRACT

Induction of basic fibroblast growth factor (bFGF) mRNA expression was studied in a Rose bengal induced focal cerebral ischemia during a time course of 2, 4, 24, 72 h and 7 days. Focal cerebral ischemia induced by Rose bengal resulted in a global upregulation in bFGF gene expression at the 24 h time-interval. This upregulation in bFGF gene expression was due to an upregulation in glial bFGF expression in most of the areas studied as seen by means of non-radioactive in situ hybridization in combination with immunocytochemistry for glial fibrillary acidic protein. However, in the piriform cortex a putative neuronal upregulation of bFGF could be detected by combination of non-radioactive in situ hybridization, immunohistochemistry for glial fibrillary acidic protein and nuclear staining with Neutral red. Semiquantitative data concerning bFGF mRNA expression were obtained by use of computer-assisted microdensitometry and revealed substantial increases in bFGF mRNA expression in the cingulate cortex, the neostriatum, a 1 mm marginal zone close to the external capsule and the olfactory tubercle at bregma levels 1 to 2 mm rostral to the lesion. No changes in bFGF gene expression were seen in field CA1 of Ammon's horn on the lesioned side and in dentate gyrus at bregma levels between -2.12 to -3.30 mm. We observed significant changes in bFGF upregulation in the caudate putamen, the piriform cortex and the amygdaloid region and the frontoparietal cortex at bregma levels -2.12 to -3.30 mm. These data indicate that photochemically induced focal cerebral ischemia leads to an early and global response in bFGF gene expression, which is due to an upregulation mainly in astrocytes. The observed widespread upregulation of the bFGF gene transcription rostral and caudal to the lesion is suggested to be due in part to neuronal glutaminergic connections between the areas investigated and in part due to increases in extracellular fluid signals (volume transmission).


Subject(s)
Brain Ischemia/chemically induced , Brain Ischemia/metabolism , Fibroblast Growth Factor 2/genetics , RNA, Messenger/metabolism , Animals , Brain/metabolism , Brain Ischemia/pathology , In Situ Hybridization , Male , Rats , Rats, Sprague-Dawley , Rose Bengal , Time Factors , Tissue Distribution
20.
Exp Brain Res ; 96(1): 89-99, 1993.
Article in English | MEDLINE | ID: mdl-8243588

ABSTRACT

We have studied the ability of the vigilance-promoting drug modafinil to counteract the ischemic lesion produced by a unilateral microinjection of endothelin-1 (ET-1) in the neostriatum of the rat using a combined morphometrical, biochemical, cardiovascular and behavioral analysis. ET-1 was injected unilaterally into the neostriatum. The ET-1-induced lesion volume, which was determined by a computer-assisted morphometrical analysis, was reduced by the 7-day modafinil treatment (10, 30, and 100 mg/kg i.p.) in a dose-related way. Modafinil also produced a dose-related counteraction of the ET-1-induced increase of perfusate lactate levels, as determined by intrastriatal microdialysis without affecting the ET-1 induced reduction of striatal blood flow, as determined by laser-Doppler flowmetry. The ipsilateral rotational behavior induced by apomorphine in the ET-1-lesioned rats was reduced dose-dependently by modafinil treatment. Thus, morphological, neurochemical, and behavioral evidence that the putative ischemic striatal injury induced by microinjection of ET-1 in the rat neostriatum is counteracted in a dose-dependent way by modafinil treatment has been obtained. The mechanism does not appear to involve an increase in striatal blood flow. It is instead speculated that its powerful preventive action in striatal ischemic injury may be related to a reduced anaerobic metabolism.


Subject(s)
Arousal/drug effects , Benzhydryl Compounds/pharmacology , Brain Ischemia/prevention & control , Endothelins/antagonists & inhibitors , Neostriatum/blood supply , Amphetamine/pharmacology , Animals , Blood Pressure/drug effects , Brain Ischemia/chemically induced , Brain Ischemia/pathology , Cerebrovascular Circulation/drug effects , Endothelins/pharmacokinetics , Endothelins/toxicity , Hemodynamics/drug effects , Injections , Lactates/blood , Lactic Acid , Male , Microdialysis , Modafinil , Neostriatum/drug effects , Neostriatum/pathology , Pyruvates/blood , Pyruvic Acid , Rats , Rats, Sprague-Dawley , Stereotaxic Techniques , Stereotyped Behavior/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...